FFWA
ABBV icon

FRG Family Wealth Advisors’s AbbVie ABBV Stock Holding History

FRG Family Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.09M Sell
23,411
-3,319
-12% -$736K 0.83% 26
2025
Q4 		$6.11M Sell
26,730
-1,230
-4% -$280K 0.95% 27
2025
Q3 		$6.47M Hold
27,960
– – 1.04% 21
2025
Q2 		$5.19M Hold
27,960
– – 0.9% 25
2025
Q1 		$5.86M Hold
27,960
– – 1.13% 24
2024
Q4 		$4.97M Hold
27,960
– – 0.9% 28
2024
Q3 		$5.52M Hold
27,960
– – 0.99% 26
2024
Q2 		$5.19M Buy
27,960
+1
+0% +$166 1.01% 27
2024
Q1 		$4.55M Sell
27,959
-170
-0.6% -$29.3K 0.89% 29
2023
Q4 		$4.36M Sell
28,129
-2
-0% -$292 0.88% 30
2023
Q3 		$4.19M Buy
+28,131
New +$4.13M 0.95% 28
2023
Q2 		– Sell
-28,429
Closed -$4.53M – 136
2023
Q1 		$4.53M Sell
28,429
-575
-2% -$87.9K 1.04% 28
2022
Q4 		$4.69M Hold
29,004
– – 1.12% 28
2022
Q3 		$3.89M Buy
29,004
+15
+0.1% +$2.15K 0.96% 28
2022
Q2 		$4.44M Hold
28,989
– – 1.03% 28
2022
Q1 		$4.7M Buy
28,989
+165
+0.6% +$24K 0.91% 31
2021
Q4 		$3.9M Sell
28,824
-661
-2% -$78.1K 0.73% 33
2021
Q3 		$3.18M Sell
29,485
-1,587
-5% -$181K 0.63% 37
2021
Q2 		$3.5M Hold
31,072
– – 0.66% 35
2021
Q1 		$3.36M Sell
31,072
-125
-0.4% -$13.4K 0.69% 36
2020
Q4 		$3.34M Sell
31,197
-125
-0.4% -$12K 0.73% 36
2020
Q3 		$2.74M Sell
31,322
-44
-0.1% -$4.14K 0.67% 40
2020
Q2 		$3.08M Buy
31,366
+164
+0.5% +$14.4K 0.81% 34
2020
Q1 		$2.38M Sell
31,202
-381
-1% -$32.5K 0.72% 38
2019
Q4 		$2.8M Sell
31,583
-6,119
-16% -$508K 0.68% 40
2019
Q3 		$2.85M Sell
37,702
-11,625
-24% -$797K 0.74% 43
2019
Q2 		$3.59M Sell
49,327
-7,826
-14% -$615K 0.94% 35
2019
Q1 		$4.61M Buy
57,153
+1,237
+2% +$101K 1.31% 22
2018
Q4 		$5.16M Buy
55,916
+1,760
+3% +$155K 1.69% 10
2018
Q3 		$5.12M Buy
54,156
+4,915
+10% +$466K 1.4% 16
2018
Q2 		$4.56M Buy
49,241
+1,250
+3% +$122K 1.36% 14
2018
Q1 		$4.54M Buy
47,991
+405
+0.9% +$44.5K 1.51% 13
2017
Q4 		$4.6M Buy
47,586
+122
+0.3% +$11.5K 1.49% 15
2017
Q3 		$4.22M Buy
47,464
+69
+0.1% +$5.25K 1.45% 15
2017
Q2 		$3.44M Buy
47,395
+352
+0.7% +$23.7K 1.27% 22
2017
Q1 		$3.08M Buy
47,043
+1,400
+3% +$88K 1.2% 26
2016
Q4 		$2.86M Buy
45,643
+7,130
+19% +$435K 1.2% 27
2016
Q3 		$2.43M Buy
38,513
+2,985
+8% +$193K 1.09% 29
2016
Q2 		$2.2M Buy
35,528
+2,131
+6% +$130K 0.99% 34
2016
Q1 		$1.9M Buy
33,397
+2,855
+9% +$159K 0.92% 39
2015
Q4 		$1.81M Buy
+30,542
New +$1.76M 0.88% 41

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FRG Family Wealth Advisors's ABBV Position: Q1 2026 in Review

FRG Family Wealth Advisors reduced its AbbVie (ABBV) stake by 12% in Q1 2026, selling an estimated $736K and leaving 23,411 shares worth $5.09M. The position accounts for 0.83% of the portfolio, ranked #26.

FRG Family Wealth Advisors first reported a position in ABBV in Q4 2015 and has held it in 41 quarters since. The position peaked at $6.47M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FRG Family Wealth Advisors held 23,411 shares of AbbVie worth $5.09M as of Q1 2026.
  • FRG Family Wealth Advisors sold 3,319 AbbVie shares in Q1 2026, an estimated $736K.
  • AbbVie made up 0.83% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #26 holding.
  • FRG Family Wealth Advisors first reported a position in AbbVie in Q4 2015 and has held it in 41 quarters since.
  • FRG Family Wealth Advisors's AbbVie position peaked at $6.47M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.